2/20
08:03 am
alks
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Bank of America Corporation from $33.00 to $34.00. They now have a "neutral" rating on the stock.
Low
Report
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Bank of America Corporation from $33.00 to $34.00. They now have a "neutral" rating on the stock.
2/12
07:30 am
alks
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Medium
Report
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
2/11
04:00 pm
alks
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
Medium
Report
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
2/2
11:12 am
alks
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Low
Report
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
1/15
07:46 am
alks
Alkermes (NASDAQ:ALKS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Alkermes (NASDAQ:ALKS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/7
04:12 am
alks
AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board [Yahoo! Finance]
Low
Report
AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board [Yahoo! Finance]
1/6
07:00 am
alks
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
Low
Report
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
1/5
09:02 pm
alks
????????????????:2032??90????????CAGR11.5%???????·???????? [CNET News]
Low
Report
????????????????:2032??90????????CAGR11.5%???????·???????? [CNET News]
12/30
04:26 pm
alks
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/30
04:00 pm
alks
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/22
07:08 am
alks
Why Analysts are Rating Alkermes (ALKS) a Buy [Yahoo! Finance]
Low
Report
Why Analysts are Rating Alkermes (ALKS) a Buy [Yahoo! Finance]
12/17
04:32 pm
alks
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
04:15 pm
alks
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Alkermes (NASDAQ:ALKS) had its "buy (b-)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
11:28 am
alks
Trends and Market Growth Opportunities in the Alcohol Use Disorder Industry, 2025-2032 [Yahoo! Finance]
Low
Report
Trends and Market Growth Opportunities in the Alcohol Use Disorder Industry, 2025-2032 [Yahoo! Finance]
12/5
04:14 pm
alks
Alkermes (NASDAQ:ALKS) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Low
Report
Alkermes (NASDAQ:ALKS) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
11/25
04:00 pm
alks
Alkermes to Participate in Two Upcoming Investor Conferences
Low
Report
Alkermes to Participate in Two Upcoming Investor Conferences
11/22
07:56 am
alks
Alkermes (NASDAQ:ALKS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Alkermes (NASDAQ:ALKS) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.